Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  MagForce AG    MF6   DE000A0HGQF5

MAGFORCE AG

(MF6)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/24/2020 11/25/2020 11/26/2020 11/27/2020 11/30/2020 Date
3.18(c) 3.12(c) 3.35(c) 3.88(c) 4.95(c) Last
111 812 61 649 57 804 96 513 177 313 Volume
+3.58% -1.89% +7.37% +15.82% +27.58% Change
More quotes
Financials
Sales 2020 2,10 M 2,50 M 2,50 M
Net income 2020 -7,53 M -8,98 M -8,98 M
Net Debt 2020 28,0 M 33,3 M 33,3 M
P/E ratio 2020 -20,1x
Yield 2020 -
Sales 2021 10,7 M 12,8 M 12,8 M
Net income 2021 -4,10 M -4,89 M -4,89 M
Net Debt 2021 34,8 M 41,5 M 41,5 M
P/E ratio 2021 -35,4x
Yield 2021 -
Capitalization 137 M 164 M 164 M
EV / Sales 2020 78,7x
EV / Sales 2021 16,0x
Nbr of Employees 29
Free-Float 72,3%
More Financials
Company
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the... 
More about the company
Notations Surperformance© of MagForce AG
Trading Rating : Investor Rating :
More Ratings
All news about MAGFORCE AG
10/30MAGFORCE : Publishes Financial Results for the First Half of 2020 and Operative ..
PU
10/30MAGFORCE : Publishes Financial Results for the First Half of 2020 and Operative ..
EQ
10/20MAGFORCE AG : 'NanoTherm School' successfully enters the third round with 'Modul..
EQ
09/21MAGFORCE : Publishes Shareholder Letter
EQ
08/13MAGFORCE : announces positive results of 2020 Annual General Meeting
EQ
07/01MAGFORCE AG : annual earnings release
06/30MAGFORCE : Publishes Financial Results for the Year 2019 and Operative Highlight..
EQ
06/24MAGFORCE : enters into an Agreement with Yorkville Advisors Global LP to issue C..
EQ
06/05MAGFORCE : and Affiliated European Clinics Support World Brain Tumor Day and Spo..
EQ
05/05MAGFORCE : Publishes Shareholder Letter
EQ
04/28MAGFORCE AG : MagForce USA, Inc. has received FDA Approval to proceed with its S..
EQ
04/27MAGFORCE AG : MagForce USA, Inc. has received FDA Approval to proceed with its S..
EQ
03/23MAGFORCE : and Hufeland Klinikum GmbH Announce Cooperation Agreement and Opening..
EQ
2019MAGFORCE : announces successful capital increase of the subsidiary MagForce USA,..
EQ
2019MAGFORCE : announces successful capital increase of the subsidiary MagForce USA,..
EQ
More news
News in other languages on MAGFORCE AG
11/12ORIGINAL-RESEARCH : MagForce AG (von GBC AG): Buy
11/12ORIGINAL-RESEARCH : MagForce AG (von GBC AG): Kaufen
10/30MAGFORCE : gibt Finanzergebnisse für das erste Halbjahr 2020 und operative Highl..
10/30MagForce AG gibt Finanzergebnisse für das erste Halbjahr 2020 und operative H..
10/30MAGFORCE : gibt Finanzergebnisse für das erste Halbjahr 2020 und operative Highl..
More news
Chart MAGFORCE AG
Duration : Period :
MagForce AG Technical Analysis Chart | MF6 | DE000A0HGQF5 | MarketScreener
Technical analysis trends MAGFORCE AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 11,86 €
Last Close Price 4,95 €
Spread / Highest target 163%
Spread / Average Target 140%
Spread / Lowest Target 122%
EPS Revisions
Managers
NameTitle
Benjamin J. Lipps Chairman-Management Board & CEO
Norbert Neef Chairman-Supervisory Board
Christian von Volkmann Chief Financial Officer
Andreas Jordan Chief Scientific Officer
Hoda Tawfik Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
MAGFORCE AG-3.00%129
MODERNA, INC.549.44%50 267
LONZA GROUP AG56.23%45 319
CELLTRION, INC.82.04%40 460
IQVIA HOLDINGS INC.9.26%32 365
SEAGEN INC.48.01%30 493